1.0 DESCRIPTION This is a Combined Synopsis/Solicitation for commercial products conducted in accordance with RFO FAR Part 12 � Acquisition of Commercial Products and Commercial Services, using the simplified procedures at RFO FAR 12.201-1. This notice serves as the solicitation. Quotations are being requested, and a separate written solicitation will not be issued. The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Environmental Health Sciences (NIEHS), intends to procure, on a sole source basis, spheroid-qualified cryopreserved primary human hepatocytes from the manufacturer, Lonza, 8830 Biggs Ford Road, Walkersville, Maryland 21793-0127. The spheroid-qualified cryopreserved primary human hepatocytes are required to support Complement-ARIE research conducted by the National Center for Advancing Translational Sciences (NCATS) and NIEHS through the Mechanistic Toxicology Branch (MTB) within the Division of Translational Toxicology (DTT). The cells will be used to develop and evaluate human three-dimensional microphysiological systems for modeling toxicity-induced human liver injury and progression toward fibrotic damage. The requirement includes 60 vials of spheroid-qualified cryopreserved primary human hepatocytes from both male and female donors to support exploratory studies, optimization of culture conditions, and evaluation of potential sex-based differences in liver injury responses. Extensive market research was conducted to identify potential sources capable of meeting the Government�s scientific and technical requirements. Multiple potential vendors were considered and contacted; however, no other vendors were identified as capable of providing the required combination of spheroid-qualified cryopreserved primary human hepatocytes, male and female donor preparations, and appropriately characterized and re-qualified cell lots suitable for the Government�s established three-dimensional liver...
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | National Institutes of Health OLAO |
|---|
| Country | United States |
|---|
| Category | Government Procurement |
|---|
| NAICS | 325414 |
|---|
| PSC | 6640 |
|---|
| Published | September 16, 2026 |
|---|
| Procurement stage | Active solicitation |
|---|
| Closed | September 21, 2026 |
|---|
| Status | Closed — no longer accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | October 11, 2026 |
|---|
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
See every United States Government Procurement opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free United States Government Procurement intelligence report in your inbox
A personalized report on United States Government Procurement opportunities, emailed in 5-10 minutes. One per month, no account needed.